Dominant A1 Flow Diverter Deployment for Bilateral-Supply Anterior Communicating Artery Aneurysms: A Single-Center Retrospective Experience in 30 Consecutive Patients

Background Anterior communicating artery (AComA) aneurysms with bilateral anterior cerebral artery (ACA) supply pose unique challenges for flow diverter (FD) deployment owing to small parent vessel caliber and hemodynamic vulnerability. Evidence supporting a dominant A1 strategy in this population remains limited. Methods Thirty consecutive adults with unruptured bilateral-supply AComA aneurysms treated with FD implanted exclusively in the dominant A1 between April 2023 and February 2026 were retrospectively identified from a single-center database (Chinese Clinical Trial Registry ChiCTR2600117882, retrospectively registered January 12, 2026). Inclusion required angiographic confirmation of bilateral ACA supply and unilateral A1 dominance (asymmetry ratio ≥ 1.1 on DSA). Preprocedural dual antiplatelet therapy (≥ 5 days) was verified by platelet function testing when available. Follow-up combined modified Rankin Scale (mRS) assessment with DSA scheduled at 6 and 12 months and annually thereafter. The primary endpoint was adequate angiographic occlusion (O'Kelly–Marotta [OKM] C + D) at last follow-up. Secondary endpoints were complete occlusion (OKM D), composite major complications, and absence of treatment-related neurological worsening (mRS stability or improvement from baseline). Results All 30 procedures were technically successful (100.0%). Median age was 59 years (interquartile range 54–62); 60.0% were male. Hyperlipidemia was present in 53.3%, hypertension in 50.0%, prior ischemic stroke in 40.0%, and admission mRS > 0 in 26.7%. Median parent vessel diameter was 2.25 mm; median A1 asymmetry ratio was 1.40, with left dominance in 63.3%. Nine FD models were used; median diameter difference < 0.3 mm in 46.7%. At a median angiographic follow-up of 7.5 months (DSA ≥ 6 months in all patients; ≥12 months in 40%), complete occlusion (OKM D) was achieved in 24/30 (80.0%) and adequate occlusion (OKM C + D) in 26/30 (86.7%), increasing to 30/30 (100.0%) when the four collar-sign borderline cases were counted as adequate. The composite major complication rate (symptomatic ischemic stroke, symptomatic intracranial hemorrhage, or mortality) was 6.7%. No patient experienced treatment-related neurological worsening. No mortality, retreatment, or loss to follow-up occurred. Conclusions Dominant A1 FD deployment is technically feasible and achieved high rates of adequate angiographic occlusion without treatment-related neurological worsening in bilateral-supply AComA aneurysms. Longer-term durability and prospective multicenter validation are warranted.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11234526/v1
Primary Topic
Intracranial Aneurysms: Treatment and Complications
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Dominant A1 Flow Diverter Deployment for Bilateral-Supply Anterior Communicating Artery Aneurysms: A Single-Center Retrospective Experience in 30 Consecutive Patients

Jing Huang, Zhejing Ding, Tao An, Guangsen Cheng et al.
Research Square
Intracranial Aneurysms: Treatment and Complications
preprint

Dominant A1 Flow Diverter Deployment for Bilateral-Supply Anterior Communicating Artery Aneurysms: A Single-Center Retrospective Experience in 30 Consecutive Patients

Jing Huang, Zhejing Ding, Tao An, Guangsen Cheng, Zhongliang Li, Tianyang Guan, Yu Liu, Dan Jin
preprint en

Abstract

Background Anterior communicating artery (AComA) aneurysms with bilateral anterior cerebral artery (ACA) supply pose unique challenges for flow diverter (FD) deployment owing to small parent vessel caliber and hemodynamic vulnerability. Evidence supporting a dominant A1 strategy in this population remains limited. Methods Thirty consecutive adults with unruptured bilateral-supply AComA aneurysms treated with FD implanted exclusively in the dominant A1 between April 2023 and February 2026 were retrospectively identified from a single-center database (Chinese Clinical Trial Registry ChiCTR2600117882, retrospectively registered January 12, 2026). Inclusion required angiographic confirmation of bilateral ACA supply and unilateral A1 dominance (asymmetry ratio ≥ 1.1 on DSA). Preprocedural dual antiplatelet therapy (≥ 5 days) was verified by platelet function testing when available. Follow-up combined modified Rankin Scale (mRS) assessment with DSA scheduled at 6 and 12 months and annually thereafter. The primary endpoint was adequate angiographic occlusion (O'Kelly–Marotta [OKM] C + D) at last follow-up. Secondary endpoints were complete occlusion (OKM D), composite major complications, and absence of treatment-related neurological worsening (mRS stability or improvement from baseline). Results All 30 procedures were technically successful (100.0%). Median age was 59 years (interquartile range 54–62); 60.0% were male. Hyperlipidemia was present in 53.3%, hypertension in 50.0%, prior ischemic stroke in 40.0%, and admission mRS > 0 in 26.7%. Median parent vessel diameter was 2.25 mm; median A1 asymmetry ratio was 1.40, with left dominance in 63.3%. Nine FD models were used; median diameter difference < 0.3 mm in 46.7%. At a median angiographic follow-up of 7.5 months (DSA ≥ 6 months in all patients; ≥12 months in 40%), complete occlusion (OKM D) was achieved in 24/30 (80.0%) and adequate occlusion (OKM C + D) in 26/30 (86.7%), increasing to 30/30 (100.0%) when the four collar-sign borderline cases were counted as adequate. The composite major complication rate (symptomatic ischemic stroke, symptomatic intracranial hemorrhage, or mortality) was 6.7%. No patient experienced treatment-related neurological worsening. No mortality, retreatment, or loss to follow-up occurred. Conclusions Dominant A1 FD deployment is technically feasible and achieved high rates of adequate angiographic occlusion without treatment-related neurological worsening in bilateral-supply AComA aneurysms. Longer-term durability and prospective multicenter validation are warranted.

Research Square
Macau University of Science and Technology (MO), University of Jinan (CN), Zhuhai People's Hospital (CN)
Good health and well-being
Intracranial Aneurysms: Treatment and Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon